• Equity PC Ratio   0.57
  • |
  • Index PC Ratio   1.14
  • |
  • Total PC Ratio   0.97
  • |
  • VIX PC Ratio   0.54
  • VIX 13.56
  • VXN 16.73
  • VXO 14.00
  • ISEE 85.00

TruCharts Trading Strategies and Stock Buy/Sell Reports
(Show Details)


Chart Settings
No saved settings found!

Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:





Indicator Windows:





NO
Refresh      
LCI (Lannett Co Inc)
Last Trade 8.06 Dividend/Share 0 PE Ratio 2.6
Date March 19-2019 Dividend Yield 0.000 Return on Assets -18.38
Change 0.18 ExDividend Date 0 Return on Capital null
Bid 0 Latest EPS 0.75 Price/Sale 0.446
Ask 0 LatestEPS Date 2018-06-30 Price to Book 0.95
Volume 28232 EPS ttm 3.100 Institutional % 115
Avg Volume 1.77M Shares Outstanding 39.29M Insider % 33
Open 7.93 Float 26.74M Short Ratio 10.210
Prev Close 7.88 Return On Equity -59.56 5 Year Change % -0.818
High 8.25 Consensus EPS 0.64 2 Year Change % -0.608
Low 7.89 No. of Estimate 3.000 1 Year Change % -0.510
52 Week High 17.575 EPS Surprise $ null YTD Change % 0.507
52 Week Low 3.33 EPS Surprise Percent 0 6 Month Change % 0.697
52 Week Change -53.095 EBITDA 0M 3 Month Change % 0.764
50 Day MA 8.2672 Revenue 0M 1 Month Change % -0.156
200 Day MA Gross Profit 0M 5 Day Change % -0.010
Market Cap 309.58M Cash 0M 30 Day Change % -0.040
Beta 2.443103 Debt 0M Stock Exchange New York Stock Exchange
Sector Healthcare Revenue Per Share 0 Short Interest 18103053
Short Date 2019-02-28 Revenue Per Employee 0 Short Ratio 10.210
Data courtesy of IEX
Company Profile

Lannett Company, Inc. develops, manufactures, markets, and distributes generic versions of pharmaceutical products in the United States. The company manufactures and/or sells various prescription products. Its product portfolio includes acetazolamide, baclofen, and bethanechol chloride tablets; amantadine gel capsules; butalbital, aspirin, and caffeine with codeine phosphate, danazol, and clindamycin HCl capsules; cocaine topical solution; and dicyclomine tablets and capsules. The company?s products also comprise digoxin, dipyridamole, doxycycline, doxycycline hyclate, esterified estrogen and methyltestoterone, hydrochlorothiazide, hydromorphone HCl, and levothyroxine sodium tablets; morphine sulfate oral solutions; and OB-natal one gel capsules. In addition, its products consist of pilocarpine HCl, primidone, probenecid, terbutaline sulfate, and unithroid tablets; oxycodone HCl oral solution; rifampin and ursodiol capsules; and phentermine HCl tablets and capsules. Lannett Company markets its products under the brand names of Diamox, Symmetrel, Lioresal, Urecholine, Fiorinal, Cleocin, Danocrine, Bentyl, Lanoxin, Persantine, Adoxa, Periostat, Estratest, Hydrodiuril, Dilaudid, Levoxyl/ Synthroid, Roxanol, PrimaCare ONE, Roxicodone, Adipex-P, Fastin, Salagen, Mysoline, Benemid, Rifadin, Brethine, Actigall, and Fiorinal w/ Codeine #3. The company sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. Lannett Company, Inc. was founded in 1942 and is based in Philadelphia, Pennsylvania.